Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Hypertension
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Hypertension
    Obesity Leading Risk Factor of Left Atrial Enlargement During Aging - (DGNews)
    TopAbstracts in Hypertension 11/25/2009 - (DGNews)
    Team-Based Care Involving a Pharmacist Improves Blood Pressure Control - (DGNews)
    Pre-eclampsia, soluble fms-like tyrosine kinase 1, and the risk of reduced thyroid function: nested case-control and population based study - (BMJ)
    TopAbstracts in Hypertension 11/18/2009 - (DGNews)

    News archive

     Recent webcasts/CME - Hypertension
    • State of the Art in Pulmonary Arterial Hypertension
    • Medication Use for Diabetes, Hypertension, and Hypercholesterolemia from 1988-1994 to 2001-2006
      Optimizing Antihypertensive Therapy and Health and Economic Outcomes in a Managed Care Environment
      Treating Coronary Artery Disease in Vulnerable Adults
      Thrombotic Thrombocytopenic Purpura: The Masquerader

      Webcasts/CME archive

       Recent cases - Hypertension
        A Woman with Swollen Fingers and New-Onset Hypertension and Renal Failure
        Hypertension
        Medical Management of a Pregnancy Woman with Moderate Renal Insufficiency and Superimposed Preclampsia
        Malignant Hypertension and Acute Aortic Dissection Associated with Caffeine-Based Ephedra-Free Dietary Supplements: A Case Report
        Giant Right Coronary Artery Aneurysm: Case Report and Literature Review

        Cases archive
          




        my personal edition > hypertension > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Amlodipine Appears To Provide Greater Reduction In Blood Pressure Than Does Losartan

        A DGReview of :"The effects of amlodipine compared to losartan in patients with mild to moderately severe hypertension."
        Journal of Clinical Hypertension (Greenwich, Conn.)

        02/06/2003
        By James Adams


        Treatment with amlodipine results in greater reductions in most blood pressure measurements when compared with losartan treatment for mild to moderately severe hypertension.

        Investigators from Lenox Hill Hospital and New York University School of Medicine compared the calcium channel blocker amlodipine with the angiotensin receptor blocker losartan in 440 adult patients with mild to moderate hypertension.

        Patients were randomized to receive either 5 milligrams of amlodipine or 50 milligrams of losartan once per day. In those patients who failed to reduce their diastolic blood pressure to 90 mm Hg or less after six weeks, amlodipine was increased to 10 milligrams daily or 12.5 milligrams of hydrochlorothiazide (HCTZ) was combined with the original dose of losartan.

        Diastolic blood pressure equal to or below 90 mm Hg was achieved by 43.6% of the amlodipine patients and 42.3% of the losartan patients. Seventy-one percent of the amlodipine and 81% of the losartan patients who continued treatment with the original dose reached blood pressure goals. The difference between the two groups was not significant.

        However, among those patients who required dosage adjustments, a significantly higher number of amlodipine patients reached blood pressure goals. Fifty-nine percent of the amlodipine patients compared with 42% of the losartan/HCTZ patients reached blood pressure goals by the end of the study.

        Combining results from high- and low-dose patients showed that 63.8% of amlodipine patients and 55.1% of losartan patients reached a diastolic blood pressure equal to or below 90 mm Hg. This difference, however, was not statistically significant.

        Amlodipine did provide a significantly greater reduction in both diastolic and systolic blood pressure from baseline to the end of treatment. Also, African American and Hispanic patients had significantly better response rates with amlodipine than with losartan.
        J Clin Hypertens (Greenwich) 2003;5:1:17-23. "The effects of amlodipine compared to losartan in patients with mild to moderately severe hypertension."

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send